## EXPE: Expedia Group, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -0.7% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($272.94)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Argus Adjusts Price Target on Expedia Group to $340 From $300, Maintains Buy Rating**
- Source: marketscreener.com | 20251229T130806 | Bullish | Relevance: 100%
- Argus has increased its price target for Expedia Group (EXPE) to $340 from $300, while reconfirming a "Buy" rating on the stock. This adjustment reflects a positive outlook on the online travel agency, which is also echoed by other analysts who have recently revised their price targets. Expedia's diverse offerings across cultural, leisure, and travel sales, alongside its hotel price comparison site Trivago, continue to position it strongly in the market.

**2. Cwm LLC Increases Stock Position in Expedia Group, Inc. $EXPE**
- Source: MarketBeat | 20251228T090514 | Somewhat-Bullish | Relevance: 100%
- Cwm LLC significantly increased its holdings in Expedia Group, Inc. (NASDAQ:EXPE) by 101.8% during the third quarter, now owning 99,888 shares worth over $21 million. This increase makes Cwm LLC a notable institutional investor in the online travel company, which recently reported strong earnings and announced a quarterly dividend. Other institutional investors have also adjusted their positions in EXPE amidst analyst forecasts for continued growth.

**3. Expedia Group (NASDAQ:EXPE) Price Target Raised to $340.00**
- Source: MarketBeat | 20251229T142727 | Bullish | Relevance: 100%
- Argus has raised its price target for Expedia Group (NASDAQ:EXPE) to $340.00 from $300.00, maintaining a "buy" rating and indicating an 18.24% potential upside. This comes after Expedia surpassed Q3 expectations with EPS of $7.57 and revenue of $4.41 billion, demonstrating strong year-over-year growth and robust financial metrics. Despite the positive outlook from some analysts, the consensus rating for EXPE remains a "Hold" with an average price target of $271.91.

**4. Annex Advisory Services LLC Makes New $26.96 Million Investment in Expedia Group, Inc. $EXPE**
- Source: MarketBeat | 20251229T083121 | Somewhat-Bullish | Relevance: 100%
- Annex Advisory Services LLC has made a new investment of $26.96 million in Expedia Group, acquiring 126,111 shares. This comes amidst significant institutional ownership at 90.76% and recent insider selling totaling $1.28 million. Analysts currently rate Expedia Group a "Hold" with an average target price of $270.66.

**5. Expedia Group, Inc. $EXPE Shares Acquired by Meyer Handelman Co.**
- Source: MarketBeat | 20251227T124059 | Somewhat-Bullish | Relevance: 100%
- Meyer Handelman Co. has increased its stake in Expedia Group, Inc. (NASDAQ:EXPE) by 11.6% in the third quarter, now owning 53,052 shares valued at approximately $11.34 million. Expedia recently surpassed quarterly earnings expectations with $7.57 EPS and $4.41 billion in revenue, showing strong financial health with a 64.15% ROE and 9.66% net margin. The company also declared a quarterly dividend of $0.40, while analysts maintain a "Hold" rating with an average target price of $270.66.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | B of A Securiti | $326 | $285 | +14% |
| 2025-12-19 | Wedbush | $290 | $250 | +16% |
| 2025-12-11 | Jefferies | $285 | $270 | +6% |
| 2025-12-11 | DA Davidson | $294 | $294 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | B of A Securiti | main | Buy |
| 2025-12-19 | Wedbush | main | Neutral |
| 2025-12-11 | Jefferies | main | Hold |
| 2025-12-11 | DA Davidson | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 9 ($0.00M) |
| Sells | 10 ($2.92M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-0.7%)
- Blackrock Inc.: 8.4% (-2.5%)
- JPMORGAN CHASE & CO: 8.2% (+168.5%)
- State Street Corpora: 4.8% (-2.4%)
- Windacre Partnership: 3.1% (+9.2%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-3.0% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +12%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.81 indicates undervaluation relative to growth. Forward P/E 16.1x attractive for 18% earnings growth. Quality metrics strong (ROE 54%). Analyst sentiment positive (3 raises, avg +12%). Insider selling cluster ($2.9M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.5B |
| Beta | 1.44 |
| 52W Range | $130.01 - $292.42 |
| Short Interest | 7.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.81 |
| Forward P/E | 16.1 |
| Current P/E | 18.9 |
| YoY Growth | 17.6% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 2.3% to -0.7% (-3.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.7pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.69% (CS: 44) | Neutral |
| RSI_14 | 65.5 | Neutral |
| MACD Histogram | -0.32 | Bearish |
| vs SMA20 | 1.038x | Above |
| vs SMA50 | 1.135x | Above |
| vs SMA200 | 1.427x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $286.82
- **Stop Loss:** $272.94 (4.8% risk)
- **Target:** $300.70 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 82
- **Position Value:** $23,519.24
- **Portfolio %:** 23.52%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-02-05 (Est: $3.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.95 | $7.57 | +9.0% |
| 2025Q2 | $4.13 | $4.24 | +2.6% |
| 2025Q1 | $0.36 | $0.40 | +11.5% |
| 2024Q4 | $2.10 | $2.39 | +14.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*